Brazil Bariatric Surgery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The brazil bariatric surgery market size was valued at USD 114.56 million in 2025 and estimated to grow from USD 119.82 million in 2026 to reach USD 149.96 million by 2031, at a CAGR of 4.59% during the forecast period (2026-2031). This report is Segmented by Device (Assisting Devices, Implantable Devices, Other Devices), Procedure Type (Sleeve Gastrectomy, Gastric Bypass, Adjustable Gastric Banding, Endoscopic Sleeve Gastroplasty, Others), and End User (Hospitals, Bariatric Surgery Centers, Others). The Market Forecasts are Provided in Terms of Value (USD).

Brazil Bariatric Surgery Market Trends and Insights

Rising obesity prevalence & government anti-obesity programs

Obesity prevalence climbed to 22.4% of Brazilian adults in 2025, a trend that fuels sustained demand for surgical intervention. The May 2025 CFM resolution broadened eligibility to patients with BMI 30-35 plus comorbidities, potentially doubling the national candidate pool. Federal investment of R$57 billion (USD 10.38 billion) targets domestic production of obesity therapies, complementing surgical pathways and supporting longer-term capacity building. Novo Nordisk’s R$6.4 billion (USD 1.17 billion) plant in Minas Gerais will supply injectables that may delay some procedures but should ultimately enlarge referral pipelines. The Brazil bariatric surgery market therefore benefits when surgery sits inside an integrated obesity-care framework that aligns pharmacotherapy and metabolic operations.

Climb in T2DM & CVD comorbidities spurring surgical referrals

Cardiologists and endocrinologists increasingly route patients toward metabolic surgery after evidence showed superior glycemic control relative to drug therapy alone. The CFM erased a prior rule that denied surgery to diabetics diagnosed more than 10 years, expanding the addressable base. Hospital Metropolitano performed 1,100 surgeries in 2024 and logged 6,432 consultations, illustrating how systematic comorbidity screening amplifies demand. Device makers now emphasize instruments that optimize anatomic reconstruction and glucose outcomes. The Brazil bariatric surgery market thus gains momentum from its repositioning as a metabolic-disease solution.

High procedure & device costs for SUS and patients

Only 31,351 of the 291,731 bariatric surgeries performed from 2020-2024 were financed by SUS, highlighting affordability constraints in the public domain. Import dependence remains heavy, with a USD 8.62 billion medical-device trade deficit in 2024. Currency swings and tariffs inflate end-user prices, slowing uptake in lower-income regions. The government plans to raise domestic medical-device production from 45% to 70% by 2033, aiming to ease the burden, but it will mature beyond the forecast window. Cost pressure, therefore, tempers long-run growth for the Brazil bariatric surgery market.

Other drivers and restraints analyzed in the detailed report include:

• Rapid adoption of minimally invasive & robotic techniques
• Expansion of private-payer DRG reimbursement
• Post-surgical complications & readmission burden

Segment Analysis

Stapling platforms are expected to account for 34.01% of the Brazilian bariatric surgery market share in 2025, largely because sleeve gastrectomy remains the primary procedure nationwide. Johnson & Johnson’s ETHICON 4000 stapler introduced 3-D staple-line formation, which reduced leak interventions by 23% and gave hospitals a measurable outcome advantage. The company plans to pair the device with its forthcoming OTTAVA robotic system, strengthening ecosystem stickiness. Gastric bands are expected to record the fastest revenue growth, expanding at a 5.44% CAGR through 2031, supported by strong uptake in premium clinics. AI-enabled laparoscopic cameras and 4-K imaging towers fall under the “other devices” category and are gaining interest for their training and accuracy benefits within the Brazilian bariatric surgery market.

Surgeons’ preference for shorter operative times and lower leak risk reinforces the dominance of stapling platforms. Innovation focuses on real-time tissue-thickness feedback and auto-adjusting staple heights to manage vascular zones. Import tariffs of 24% on mechanical staplers are pushing suppliers to evaluate local assembly, aligning with the health-industrial-complex blueprint. Endoscopic sleeve gastroplasty disposables carry premium price tags but improve patient throughput by reducing the average stay by 2-4 days in private centers. These dynamics collectively shape the Brazil bariatric surgery market size trajectory at the device level.

Complete Report Scope:

• By Device
  • Assisting Devices
    • Suturing Devices
    • Closure Devices
    • Stapling Devices
    • Other Assisting Devices
  • Implantable Devices
    • Gastric Balloons
    • Gastric Bands
    • Silastic Rings & Meshes
  • Other Devices
• By Procedure Type
  • Sleeve Gastrectomy
  • Gastric Bypass
  • Adjustable Gastric Banding
  • Endoscopic Sleeve Gastroplasty
  • Others
• By End User
  • Hospitals
  • Bariatric Surgery Centers
  • Others

List of Companies Covered in this Report:

• Apollo Endosurgery
• Asensus Surgical
• B. Braun
• Johnson & Johnson
• Medtronic
• Spatz Medical
• USGI Medical
• Intuitive Surgical
• Olympus
• Teleflex (Standard Bariatrics)
• ReShape Lifescience
• Cousin Surgery
• Allurion Technologies
• Bariatric Solutions
• Silimed
• Conmed
• Stryker
• Aspire Bariatrics
• EndoGastric Solutions
• Nordic Gastric Balloon

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support